NCT06180525 (COLLARS) is a clinical trial in Bone Tumor, sponsored by Regina Elena Cancer Institute.

Who is sponsoring NCT06180525?

NCT06180525 is sponsored by Regina Elena Cancer Institute.

What condition does NCT06180525 study?

NCT06180525 studies Bone Tumor.

Is NCT06180525 still recruiting?

NCT06180525 is currently status unknown. Last updated 22 March 2024.

Last reviewed 2024-03-22 · How we verify

NCT06180525: COLLARS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radiological Evaluation of 3D Printed Porous Collars in Hip and Knee Resection Prostheses: Pilot Study.

Status unknown Last updated 22 March 2024

What this trial tests

trial in Bone Tumor in 30 participants. Status unknown.

Timeline

1 December 2022

Primary endpoint
1 June 2024

1 June 2024

Quick facts

Lead sponsor	Regina Elena Cancer Institute
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 December 2022
Primary completion	1 June 2024
Estimated completion	1 June 2024
Sites	1 location across Italy

Conditions studied

Bone Tumor — all drugs for Bone Tumor →

Sponsor

Regina Elena Cancer Institute

Who can join

18 and older, any sex, with Bone Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the osseointegration of 3D printed porous collars in hip and knee resection prostheses, in order to eliminate one of the causes of diaphyseal osteolysis, which often lead to loosening of the implants, and therefore to guarantee a further improvement in fixation of the implants in terms of both primary and secondary stability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bone Tumor

Currently open trials in the same condition.

NCT06171282 — A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors · EARLY_PHASE1 · recruiting
NCT05779670 — Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery · recruiting

Other Regina Elena Cancer Institute trials

Trials by the same sponsor.

NCT07256769 — Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis · recruiting
NCT07248878 — Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy · recruiting
NCT07258186 — Generation of Endometrial Carcinoma Organoids · recruiting
NCT07018037 — Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma · recruiting
NCT06894628 — Genomics and Efficacy of Post-prostatectomy Salvage Radiotherapy With 'Extreme' Hypofractionation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06180525 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Regina Elena Cancer Institute
Last refreshed: 22 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06180525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing